These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 27054598

  • 1. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
    Juan L, Huamei M, Zhe S, Yanhong L, Hongshan C, Qiuli C, Jun Z, Song G, Minlian D.
    J Pediatr Endocrinol Metab; 2016 Jul 01; 29(7):841-8. PubMed ID: 27054598
    [Abstract] [Full Text] [Related]

  • 2. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
    Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
    Clin Endocrinol (Oxf); 2002 Nov 01; 57(5):669-76. PubMed ID: 12390343
    [Abstract] [Full Text] [Related]

  • 3. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
    Hargitai G, Sólyom J, Battelino T, Lebl J, Pribilincová Z, Hauspie R, Kovács J, Waldhauser F, Frisch H, MEWPE-CAH Study Group.
    Horm Res; 2001 Nov 01; 55(4):161-71. PubMed ID: 11598369
    [Abstract] [Full Text] [Related]

  • 4. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
    Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP.
    J Clin Endocrinol Metab; 2009 Oct 01; 94(10):3882-8. PubMed ID: 19622620
    [Abstract] [Full Text] [Related]

  • 5. Adult height of children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Tsai MM, Tsai WY, Lee CT, Liu SY, Chien YH, Tung YC.
    J Formos Med Assoc; 2023 Feb 01; 122(2):106-112. PubMed ID: 36155706
    [Abstract] [Full Text] [Related]

  • 6. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
    Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
    J Clin Endocrinol Metab; 2007 May 01; 92(5):1635-9. PubMed ID: 17299071
    [Abstract] [Full Text] [Related]

  • 7. Outcome of gonadotropin-releasing analog treatment for children with central precocious puberty: 15-year experience in southern Thailand.
    Jaruratanasirikul S, Thaiwong M.
    J Pediatr Endocrinol Metab; 2011 May 01; 24(7-8):519-23. PubMed ID: 21932591
    [Abstract] [Full Text] [Related]

  • 8. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
    Bretones P, Riche B, Pichot E, David M, Roy P, Tardy V, Kassai B, Gaillard S, Bernoux D, Morel Y, Chatelain P, Nicolino M, Cornu C, French Collaborative CAH Growth Study Group.
    J Pediatr Endocrinol Metab; 2016 Dec 01; 29(12):1379-1388. PubMed ID: 27852974
    [Abstract] [Full Text] [Related]

  • 9. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
    Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
    J Pediatr; 2015 Mar 01; 166(3):743-50. PubMed ID: 25557963
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
    Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
    J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
    [Abstract] [Full Text] [Related]

  • 11. Final height of patients with classical congenital adrenal hyperplasia.
    Aycan Z, Akbuğa S, Cetinkaya E, Ocal G, Berberoğlu M, Evliyaoğlu O, Adiyaman P.
    Turk J Pediatr; 2009 Oct 25; 51(6):539-44. PubMed ID: 20196386
    [Abstract] [Full Text] [Related]

  • 12. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
    Bonfig W, Schwarz HP.
    Horm Res Paediatr; 2011 Oct 25; 75(4):264-8. PubMed ID: 21196707
    [Abstract] [Full Text] [Related]

  • 13. Near-final height in patients with congenital adrenal hyperplasia treated with combined therapy using GH and GnRHa.
    Longui CA, Kochi C, Calliari LE, Modkovski MB, Soares M, Alves EF, Prudente FV, Monte O.
    Arq Bras Endocrinol Metabol; 2011 Nov 25; 55(8):661-4. PubMed ID: 22218451
    [Abstract] [Full Text] [Related]

  • 14. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P, Suphasit R, Mahachoklertwattana P.
    Gynecol Endocrinol; 2011 Aug 25; 27(8):524-8. PubMed ID: 21501002
    [Abstract] [Full Text] [Related]

  • 15. Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Trinh L, Nimkarn S, New MI, Lin-Su K.
    J Pediatr Endocrinol Metab; 2007 Aug 25; 20(8):883-91. PubMed ID: 17937061
    [Abstract] [Full Text] [Related]

  • 16. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Muirhead S, Sellers EA, Guyda H, Canadian Pediatric Endocrine Group.
    J Pediatr; 2002 Aug 25; 141(2):247-52. PubMed ID: 12183722
    [Abstract] [Full Text] [Related]

  • 17. Restoration of Height after 11 Years of Letrozole Treatment in 11β-Hydroxylase Deficiency.
    Atay Z, Turan S, Buğdaycı O, Guran T, Bereket A.
    Horm Res Paediatr; 2019 Aug 25; 92(3):203-208. PubMed ID: 31454824
    [Abstract] [Full Text] [Related]

  • 18. Non-classical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height.
    Weintrob N, Dickerman Z, Sprecher E, Galatzer A, Pertzelan A.
    Eur J Endocrinol; 1997 Feb 25; 136(2):188-95. PubMed ID: 9116914
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
    Quintos JB, Vogiatzi MG, Harbison MD, New MI.
    J Clin Endocrinol Metab; 2001 Apr 25; 86(4):1511-7. PubMed ID: 11297576
    [Abstract] [Full Text] [Related]

  • 20. Growth and development in children with classic congenital adrenal hyperplasia.
    Bonfig W.
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb 25; 24(1):39-42. PubMed ID: 27898585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.